APA (7th ed.) Citation

KY, L., K, G., F, F., QH, C., JR, X., LQ, Z., & WL, C. (2026). The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure. Acta pharmacologica Sinica. https://doi.org/10.1038/s41401-026-01827-4

Chicago Style (17th ed.) Citation

KY, Liu, Gong K, Fang F, Chen QH, Xu JR, Zhang LQ, and Chen WL. "The Solute Carrier Transporter SLCO5A1 as a Novel Therapeutic Target for the Treatment of Myocardial Infarction-induced Heart Failure." Acta Pharmacologica Sinica 2026. https://doi.org/10.1038/s41401-026-01827-4.

MLA (9th ed.) Citation

KY, Liu, et al. "The Solute Carrier Transporter SLCO5A1 as a Novel Therapeutic Target for the Treatment of Myocardial Infarction-induced Heart Failure." Acta Pharmacologica Sinica, 2026, https://doi.org/10.1038/s41401-026-01827-4.